Heron Therapeutics, Inc. (HRTX) vs MindWalk Holdings Corp. (HYFT)

A side-by-side comparison of Heron Therapeutics, Inc. and MindWalk Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HRTX vs HYFT

growth of $100 · dividends reinvested · last 10y
HRTX -97.0% (-29.6%/yr)HYFT -66.0% (-10.2%/yr)HYFT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002019202120232025$3$34
HRTX HYFT

HRTX vs HYFT: by the numbers

  • •HYFT is the larger company ($70M vs $64M market cap).
  • •Both run net losses; HRTX's is the smaller (-22.52% vs -105.29% net margin).
  • •HRTX grew revenue faster over the past five years (12.73% vs -4.48% CAGR).

Metrics side by side

Valuation

MetricHRTXHYFT
P/S ratio0.425.99
P/B ratio10.8414.25

Profitability

MetricHRTXHYFT
Gross margin70.07%60.78%
Operating margin-7.19%-96.01%
Net margin-22.52%-105.29%
ROE-492.89%-250.39%
ROIC-6.79%-153.46%

Growth (annualized)

MetricHRTXHYFT
Revenue CAGR (5Y)12.73%-4.48%
Total return CAGR (5Y)-48.61%-23.93%

Frequently asked

Which has grown faster, HRTX or HYFT?
Over the past five years, HRTX grew revenue faster — HRTX at a 12.73% CAGR versus HYFT at -4.48%.
How have HRTX and HYFT total returns compared?
Over the past 5 years, HRTX delivered -48.61% and HYFT delivered -23.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.